Skip to main navigation Skip to search Skip to main content

The role of the KIDS for enhancing drug safety and risk management in Korea

Research output: Contribution to journalReview articlepeer-review

Abstract

Pharmacovigilance is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem. The Korea Institute of Drug Safety and Risk Management (KIDS) was established in April 2012. The main missions of the KIDS are to collect, analyze, evaluate, and manage adverse drug reaction (ADR) data, develop drug utilization review (DUR) criteria, distribute medication guidelines for health professionals, perform retrospective DUR, and perform causality assessment on ADRs, or signals derived from spontaneous reporting or other sources. The KIDS aims to provide evidence to enhance national health quality through a better drug safety and risk management system in Korea. The purpose of this paper is to suggest possible approaches and the KIDS's role in strengthening the pharmacovigilance system in Korea.

Original languageEnglish
Pages (from-to)861-868
Number of pages8
JournalJournal of the Korean Medical Association
Volume55
Issue number9
DOIs
StatePublished - Sep 2012
Externally publishedYes

Keywords

  • Drug utilization review
  • Pharamcoepidemiology
  • Pharmacovigilance
  • Risk management

Fingerprint

Dive into the research topics of 'The role of the KIDS for enhancing drug safety and risk management in Korea'. Together they form a unique fingerprint.

Cite this